Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 5.55
+0.14 (2.59%)
Oct 10, 2025, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 1.51 billion as of October 10, 2025. Its market cap has increased by 237.34% in one year.
Market Cap
1.51B
Enterprise Value
1.58B
Revenue
50.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.55
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 1.51B, a decrease of -9.35%. That is a compound annual growth rate of -1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1.51B | 352.03% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | 11.53B | 63.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 103.82B |
| Sectra AB | 58.15B |
| Getinge AB | 56.27B |
| Camurus AB | 41.07B |
| Medicover AB | 39.41B |
| Asker Healthcare Group AB | 32.35B |
| BioArctic AB | 25.79B |
| AddLife AB | 22.34B |